DV Stent tracheal
- Home
- PNEUMOLOGY
- DV Stent tracheal
Are you interested
in this
product?
DV Stent tracheal
Basic description
The DV Stent Tracheal is a worldwide unique self-expandable tracheal biodegradable stent that degrades in the human body usually 3 to 4 months after the implantation. Therefore, it is an ideal solution for temporary use in benign indications, where it is not necessary to extract it from the body like other non-degradable stents.
Product is available as custom-made device.
CE mark pending
Indication
DV Stent Tracheal is intended for patients aged 18 and older and is indicated for the treatment of benign tracheal stenoses unless primary surgery is indicated.
Features / Benefits
The DV Stent Tracheal degrades in the human body usually in 3 to 4 months. This reduces the number of interventions and hospital visits.
The stent is made of polydioxanone, an absorbable material (polymer) used in medicine as a surgical suture for more than 30 years.
Stent integrity and radial force are maintained for 6 to 8 weeks of implantation. Subsequently, the radial force gradually decreases until the degradation of the material after 3 to 4 months.
The pH value affects the stent degradation process. At higher pH, stent degradation is slower, at lower pH, stent degradation is faster.
Low migration is achieved by uncovered stent design.
Polydioxanone is not visible under X-ray, therefore the stent is equipped with gold markers – 1 piece at both stent ends.
MRI compatibility – “MR Conditional”, compatible with 1.5 Tesla and 3 Tesla static magnetic field.
Implantation
The stent is supplied sterile and is packed separately from the delivery system. Just prior to implantation, the stent must be manually compressed into the delivery system. The stent is inserted under bronchoscopic control through a rigid bronchoscope.
Available sizes
REF No. | Nominal stent body diameter [mm] | Nominal stent length [mm] | Delivery system |
---|---|---|---|
019-IU-16-040-DV | 16 | 40 | 26 F / 18 F 60 cm |
019-IU-16-050-DV | 50 | ||
019-IU-16-060-DV | 60 | ||
019-IU-16-070-DV | 70 | ||
019-IU-18-040-DV | 18 | 40 | |
019-IU-18-050-DV | 50 | ||
019-IU-18-060-DV | 60 | ||
019-IU-18-070-DV | 70 | ||
019-IU-20-040-DV | 20 | 40 | |
019-IU-20-050-DV | 50 | ||
019-IU-20-060-DV | 60 | ||
019-IU-20-070-DV | 70 |
Video
Publications
Biodegradable tracheal stents: our ten-year experience with adult patients
Ludek Stehlik, Debarya Guha, Sheetal Anandakumar, Alice Taskova and Martina Koziar Vasakova
BMC Pulm Med 24, 238 (2024).doi.org/10.1186/s12890-024-03057-y. PMID: 38750487 PMCID: PMC11094873
Single-center review on safety of biodegradable airway stenting in pediatric population
Federico Minen, Andrew Durward, Paul James, Athanasios Diamantopoulos, Haran Jogeesvaran, Gareth J Morgan, Andrew Nyman
Pediatr Pulmonol. 2023;1‐10., DOI: 10.1002/ppul.26670, PMID: 37728230
Further experience with polydioxanone airway stents in children
Rocío Morante-Valverde, María López Díaz, Mª Carmen Luna-Paredes, Sara Proaño, Cecilia Castellano, Mª Dolores Méndez, Victoria Ramos, Juan L Antón-Pacheco
Pediatr Pulmonol. 2024 Oct;59(10):2517-2522. doi: 10.1002/ppul.27056. Epub 2024 May 9. PMID: 38721899
First experience with biodegradable airway stents in children
Vondrys D, Elliott MJ, McLaren CA, Noctor C, Roebuck DJ
Ann Thorac Surg. 2011 Nov;92(5):1870-4. doi: 10.1016/j.athoracsur.2011.07.042. Epub 2011 Oct 31. PMID: 22051281
The role of bioresorbable intraluminal airway stents in pediatric tracheobronchial obstruction: A systematic review
Stramiello JA, Mohammadzadeh A, Ryan J, Brigger MT
Int J Pediatr Otorhinolaryngol. 2020 Dec;139:110405. doi: 10.1016/j.ijporl.2020.110405. Epub 2020 Sep 30. PMID: 33017664